Meropenem heteroresistance in clinical isolates of OXA-48–producing Klebsiella pneumoniae
Resumen: OXA-48–producing Klebsiella pneumoniae isolates often show growth of colonies within inhibition zones in carbapenem diffusion assays. The nature of these colonies was investigated in a series of clinical isolates of OXA-48–producing K. pneumoniae obtained in the context of a hospital outbreak, and they were found to be persistent colonies that reproduced again the same phenotype when they were collected and tested in diffusion assays again. The frequency of mutations conferring resistance to meropenem (8 µg/mL) was determined for the same isolates. The average mutation frequency was 5.47·10-6 (range: 2.59·10-8–5.87·10-5), and the analysis of several resistant mutants showed that all of them had mutations in the ompK36 porin gene. Heteroresistance was investigated using population analysis profiling. The profiles were compatible with mutation frequency assays, and all the colonies analyzed were resistant mutants. In OXA-48–producing K. pneumoniae, the growth of persisters seems to be specific of diffusion assays.
Idioma: Inglés
DOI: 10.1016/j.diagmicrobio.2018.09.008
Año: 2018
Publicado en: Diagnostic Microbiology and Infectious Disease 93, 2 (2018), 162 - 166
ISSN: 0732-8893

Factor impacto JCR: 2.314 (2018)
Categ. JCR: MICROBIOLOGY rank: 90 / 133 = 0.677 (2018) - Q3 - T3
Categ. JCR: INFECTIOUS DISEASES rank: 54 / 89 = 0.607 (2018) - Q3 - T2

Factor impacto SCIMAGO: 1.125 - Infectious Diseases (Q1) - Microbiology (medical) (Q1) - Medicine (miscellaneous) (Q1)

Financiación: info:eu-repo/grantAgreement/ES/ISCIII-FEDER/PI14-01832
Financiación: info:eu-repo/grantAgreement/ES/MINECO-FEDER/ISCIII-REIPI-RD12-0015
Financiación: info:eu-repo/grantAgreement/ES/MINECO-FEDER/ISCIII-REIPI-RD16-0016
Tipo y forma: Artículo (PostPrint)
Área (Departamento): Area Medicina (Dpto. Medicina, Psiqu. y Derm.)

Creative Commons Debe reconocer adecuadamente la autoría, proporcionar un enlace a la licencia e indicar si se han realizado cambios. Puede hacerlo de cualquier manera razonable, pero no de una manera que sugiera que tiene el apoyo del licenciador o lo recibe por el uso que hace. No puede utilizar el material para una finalidad comercial. Si remezcla, transforma o crea a partir del material, no puede difundir el material modificado.


Exportado de SIDERAL (2020-05-13-00:51:22)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
Artículos



 Registro creado el 2019-10-25, última modificación el 2020-05-13


Postprint:
 PDF
Valore este documento:

Rate this document:
1
2
3
 
(Sin ninguna reseña)